Stroke Prevention in Atrial Fibrillation

Published Online: Tuesday, January 14, 2014
Follow Pharmacy_Times:
For this podcast, produced by the American Society of Health-System Pharmacists, 3 pharmacists were interviewed on issues relating to preventing stroke in atrial fibrillation. The interviewees are: James Kalus, PharmD, senior manager of patient care services in the department of pharmacy at Henry Ford Hospital in Detroit; Cynthia Sanoski, PharmD, chair and associate professor in the department of pharmacy practice at Jefferson School of Pharmacy at Thomas Jefferson University in Philadelphia; and Nancy Shapiro, PharmD, clinical associate professor in the department of pharmacy practice at the University of Illinois at Chicago College of Pharmacy.
 
To listen to this podcast, click here.
Related Articles
While the FDA only recommends daily aspirin for patients who have experienced major cardiovascular events, about half of older adults in the United States take aspirin regularly.
Health-system pharmacists must not forget the importance of a strong working relationship with nurses.
Pharmacist-driven drug management programs best ensure atrial fibrillation patients adhere to the warfarin alternative, dabigatran (Pradaxa).
The recent outbreak of a drug-resistant strain of shigellosis is giving pharmacists an important role in preventing and treating the gastrointestinal disease.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$